{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T19:22:30Z","timestamp":1789932150368,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T00:00:00Z","timestamp":1494979200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00296-017-3740-3","type":"journal-article","created":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T23:22:08Z","timestamp":1494976928000},"page":"129-136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency"],"prefix":"10.1007","volume":"38","author":[{"given":"Sezgin","family":"Sahin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amra","family":"Adrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenan","family":"Barut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdal","family":"Ugurlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eda Tahir","family":"Turanli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huri","family":"Ozdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1125-7720","authenticated-orcid":false,"given":"Ozgur","family":"Kasapcopur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,17]]},"reference":[{"issue":"10","key":"3740_CR1","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJMoa1307362","volume":"370","author":"P Navon Elkan","year":"2014","unstructured":"Navon Elkan P, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, Zlotogorski A, Berkun Y, Press JJ, Mukamel M, Voth I, Hashkes PJ, Harel L, Hoffer V, Ling E, Yalcinkaya F, Kasapcopur O, Lee MK, Klevit RE, Renbaum P, Weinberg-Shukron A, Sener EF, Schormair B, Zeligson S, Marek-Yagel D, Strom TM, Shohat M, Singer A, Rubinow A, Pras E, Winkelmann J, Tekin M, Anikster Y, King MC, Levy-Lahad E (2014) Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med 370(10):921\u2013931. doi:\n                        10.1056\/NEJMoa1307362","journal-title":"N Engl J Med"},{"issue":"10","key":"3740_CR2","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1307361","volume":"370","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, Stone DL, Chae JJ, Rosenzweig SD, Bishop K, Barron KS, Kuehn HS, Hoffmann P, Negro A, Tsai WL, Cowen EW, Pei W, Milner JD, Silvin C, Heller T, Chin DT, Patronas NJ, Barber JS, Lee CC, Wood GM, Ling A, Kelly SJ, Kleiner DE, Mullikin JC, Ganson NJ, Kong HH, Hambleton S, Candotti F, Quezado MM, Calvo KR, Alao H, Barham BK, Jones A, Meschia JF, Worrall BB, Kasner SE, Rich SS, Goldbach-Mansky R, Abinun M, Chalom E, Gotte AC, Punaro M, Pascual V, Verbsky JW, Torgerson TR, Singer NG, Gershon TR, Ozen S, Karadag O, Fleisher TA, Remmers EF, Burgess SM, Moir SL, Gadina M, Sood R, Hershfield MS, Boehm M, Kastner DL, Aksentijevich I (2014) Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med 370(10):911\u2013920. doi:\n                        10.1056\/NEJMoa1307361","journal-title":"N Engl J Med"},{"issue":"6","key":"3740_CR3","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00431-014-2320-8","volume":"173","author":"N Garg","year":"2014","unstructured":"Garg N, Kasapcopur O, Foster J 2nd, Barut K, Tekin A, Kizilkilic O, Tekin M (2014) Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy. Eur J Pediatr 173(6):827\u2013830. doi:\n                        10.1007\/s00431-014-2320-8","journal-title":"Eur J Pediatr"},{"issue":"8","key":"3740_CR4","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3899\/jrheum.150024","volume":"42","author":"ED Batu","year":"2015","unstructured":"Batu ED, Karadag O, Taskiran EZ, Kalyoncu U, Aksentijevich I, Alikasifoglu M, Ozen S (2015) A case series of adenosine deaminase 2-deficient patients emphasizing treatment and genotype\u2013phenotype correlations. J Rheumatol 42(8):1532\u20131534. doi:\n                        10.3899\/jrheum.150024","journal-title":"J Rheumatol"},{"issue":"9","key":"3740_CR5","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/art.39699","volume":"68","author":"S Nanthapisal","year":"2016","unstructured":"Nanthapisal S, Murphy C, Omoyinmi E, Hong Y, Standing A, Berg S, Ekelund M, Jolles S, Harper L, Youngstein T, Gilmour K, Klein NJ, Eleftheriou D, Brogan PA (2016) Deficiency of adenosine deaminase type 2: a description of phenotype and genotype in fifteen cases. Arthr Rheumatol 68(9):2314\u20132322. doi:\n                        10.1002\/art.39699","journal-title":"Arthr Rheumatol"},{"issue":"5","key":"3740_CR6","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/rheumatology\/kev439","volume":"55","author":"JM Montfrans Van","year":"2016","unstructured":"Van Montfrans JM, Hartman EA, Braun KP, Hennekam EA, Hak EA, Nederkoorn PJ, Westendorp WF, Bredius RG, Kollen WJ, Scholvinck EH, Legger GE, Meyts I, Liston A, Lichtenbelt KD, Giltay JC, Van Haaften G, De Vries Simons GM, Leavis H, Sanders CJ, Bierings MB, Nierkens S, Van Gijn ME (2016) Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations. Rheumatology (Oxford) 55(5):902\u2013910. doi:\n                        10.1093\/rheumatology\/kev439","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"3740_CR7","doi-asserted-by":"publisher","first-page":"283.e285","DOI":"10.1016\/j.jaci.2014.10.010","volume":"135","author":"L Eyck Van Jr","year":"2015","unstructured":"Van Eyck L Jr, Hershfield MS, Pombal D, Kelly SJ, Ganson NJ, Moens L, Frans G, Schaballie H, De Hertogh G, Dooley J, Bossuyt X, Wouters C, Liston A, Meyts I (2015) Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol 135(1):283.e285\u2013287.e285. doi:\n                        10.1016\/j.jaci.2014.10.010","journal-title":"J Allergy Clin Immunol"},{"key":"3740_CR8","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jpeds.2016.06.058","volume":"177","author":"T Ben-Ami","year":"2016","unstructured":"Ben-Ami T, Revel-Vilk S, Brooks R, Shaag A, Hershfield MS, Kelly SJ, Ganson NJ, Kfir-Erenfeld S, Weintraub M, Elpeleg O, Berkun Y, Stepensky P (2016) Extending the clinical phenotype of adenosine deaminase 2 deficiency. J Pediatr 177:316\u2013320. doi:\n                        10.1016\/j.jpeds.2016.06.058","journal-title":"J Pediatr"},{"issue":"1","key":"3740_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12969-016-0111-7","volume":"14","author":"R Caorsi","year":"2016","unstructured":"Caorsi R, Penco F, Schena F, Gattorno M (2016) Monogenic polyarteritis: the lesson of ADA2 deficiency. Pediatr Rheumatol Online J 14(1):51. doi:\n                        10.1186\/s12969-016-0111-7","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"3740_CR10","doi-asserted-by":"publisher","first-page":"e000236","DOI":"10.1136\/rmdopen-2015-000236","volume":"2","author":"F Uettwiller","year":"2016","unstructured":"Uettwiller F, Sarrabay G, Rodero MP, Rice GI, Lagrue E, Marot Y, Deiva K, Touitou I, Crow YJ, Quartier P (2016) ADA2 deficiency: case report of a new phenotype and novel mutation in two sisters. RMD Open 2(1):e000236. doi:\n                        10.1136\/rmdopen-2015-000236","journal-title":"RMD Open"},{"issue":"3","key":"3740_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10875-016-0245-x","volume":"36","author":"J Schepp","year":"2016","unstructured":"Schepp J, Bulashevska A, Mannhardt-Laakmann W, Cao H, Yang F, Seidl M, Kelly S, Hershfield M, Grimbacher B (2016) Deficiency of adenosine deaminase 2 causes antibody deficiency. J Clin Immunol 36(3):179\u2013186. doi:\n                        10.1007\/s10875-016-0245-x","journal-title":"J Clin Immunol"},{"issue":"4","key":"3740_CR12","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1007\/s00415-016-8070-y","volume":"263","author":"O Poswar Fde","year":"2016","unstructured":"Poswar Fde O, da Fonseca RM, de Albuquerque LC, Zhou Q, Jardim LB, Monte TL, Aksentijevich I, Saute JA (2016) Adenosine deaminase 2 deficiency presenting as spastic paraplegia and systemic vasculitis. J Neurol 263(4):818\u2013820. doi:\n                        10.1007\/s00415-016-8070-y","journal-title":"J Neurol"},{"key":"3740_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1546-0096-12-44","volume":"12","author":"A Belot","year":"2014","unstructured":"Belot A, Wassmer E, Twilt M, Lega JC, Zeef LA, Oojageer A, Kasher PR, Mathieu AL, Malcus C, Demaret J, Fabien N, Collardeau-Frachon S, Mechtouff L, Derex L, Walzer T, Rice GI, Durieu I, Crow YJ (2014) Mutations in CECR1 associated with a neutrophil signature in peripheral blood. Pediatr Rheumatol Online J 12:44. doi:\n                        10.1186\/1546-0096-12-44","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"3740_CR14","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1056\/NEJMc1405506#SA3","volume":"371","author":"J Bras","year":"2014","unstructured":"Bras J, Guerreiro R, Santo GC (2014) Mutant ADA2 in vasculopathies. N Engl J Med 371(5):478\u2013480. doi:\n                        10.1056\/NEJMc1405506#SA3","journal-title":"N Engl J Med"},{"issue":"5","key":"3740_CR15","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1056\/NEJMc1405506#SA4","volume":"371","author":"L Eyck Van","year":"2014","unstructured":"Van Eyck L, Liston A, Wouters C (2014) Mutant ADA2 in vasculopathies. N Engl J Med 371(5):480. doi:\n                        10.1056\/NEJMc1405506#SA4","journal-title":"N Engl J Med"},{"issue":"5","key":"3740_CR16","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1056\/NEJMc1405506#SA2","volume":"371","author":"L Eyck Van","year":"2014","unstructured":"Van Eyck L, Liston A, Meyts I (2014) Mutant ADA2 in vasculopathies. N Engl J Med 371(5):478\u2013479. doi:\n                        10.1056\/NEJMc1405506#SA2","journal-title":"N Engl J Med"},{"issue":"5","key":"3740_CR17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJMc1407114","volume":"371","author":"R Segel","year":"2014","unstructured":"Segel R, King MC, Levy-Lahad E (2014) Mutant ADA2 in vasculopathies. N Engl J Med 371(5):481","journal-title":"N Engl J Med"},{"issue":"5","key":"3740_CR18","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1056\/NEJMc1405506#SA1","volume":"371","author":"J Montfrans van","year":"2014","unstructured":"van Montfrans J, Zavialov A, Zhou Q (2014) Mutant ADA2 in vasculopathies. N Engl J Med 371(5):478. doi:\n                        10.1056\/NEJMc1405506#SA1","journal-title":"N Engl J Med"},{"key":"3740_CR19","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1597611","author":"M Elbracht","year":"2016","unstructured":"Elbracht M, Mull M, Wagner N, Kuhl C, Abicht A, Kurth I, Tenbrock K, Hausler M (2016) Stroke as initial manifestation of adenosine deaminase 2 deficiency. Neuropediatrics. doi:\n                        10.1055\/s-0036-1597611","journal-title":"Neuropediatrics"},{"issue":"6","key":"3740_CR20","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/rheumatology\/kew050","volume":"55","author":"N Keer","year":"2016","unstructured":"Keer N, Hershfield M, Caskey T, Unizony S (2016) Novel compound heterozygous variants in CECR1 gene associated with childhood onset polyarteritis nodosa and deficiency of ADA2. Rheumatology (Oxford) 55(6):1145\u20131147. doi:\n                        10.1093\/rheumatology\/kew050","journal-title":"Rheumatology (Oxford)"},{"issue":"20","key":"3740_CR21","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1212\/wnl.0000000000001581","volume":"84","author":"WF Westendorp","year":"2015","unstructured":"Westendorp WF, Nederkoorn PJ, Aksentijevich I, Hak AE, Lichtenbelt KD, Braun KP (2015) Unexplained early-onset lacunar stroke and inflammatory skin lesions: consider ADA2 deficiency. Neurology 84(20):2092\u20132093. doi:\n                        10.1212\/wnl.0000000000001581","journal-title":"Neurology"},{"issue":"11","key":"3740_CR22","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1001\/jamadermatol.2015.1635","volume":"151","author":"TM Gonzalez Santiago","year":"2015","unstructured":"Gonzalez Santiago TM, Zavialov A, Saarela J, Seppanen M, Reed AM, Abraham RS, Gibson LE (2015) Dermatologic features of ADA2 deficiency in cutaneous polyarteritis nodosa. JAMA Dermatol 151(11):1230\u20131234. doi:\n                        10.1001\/jamadermatol.2015.1635","journal-title":"JAMA Dermatol"},{"issue":"2","key":"3740_CR23","doi-asserted-by":"publisher","first-page":"628.e622","DOI":"10.1016\/j.jaci.2016.03.016","volume":"138","author":"AP Hsu","year":"2016","unstructured":"Hsu AP, West RR, Calvo KR, Cuellar-Rodriguez J, Parta M, Kelly SJ, Ganson NJ, Hershfield MS, Holland SM, Hickstein DD (2016) Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: successful hematopoietic stem cell transplantation. J Allergy Clin Immunol 138(2):628.e622\u2013630.e622. doi:\n                        10.1016\/j.jaci.2016.03.016","journal-title":"J Allergy Clin Immunol"},{"key":"3740_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000805","author":"H Hashem","year":"2017","unstructured":"Hashem H, Egler R, Dalal J (2017) Refractory pure red cell aplasia manifesting as deficiency of adenosine deaminase 2. J Pediatr Hematol Oncol. doi:\n                        10.1097\/MPH.0000000000000805\n                        \n                     (Epub ahead of print)","journal-title":"J Pediatr Hematol Oncol"},{"issue":"11","key":"3740_CR25","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31(11):1409\u20131417. doi:\n                        10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-017-3740-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3740-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3740-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T07:05:39Z","timestamp":1515481539000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-017-3740-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,17]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["3740"],"URL":"https:\/\/doi.org\/10.1007\/s00296-017-3740-3","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,17]]}}}